A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as mirtazapine during clinical.
J Child Adolesc Psychopharmacol. 2004 Summer;14(2):175-84. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter.
Mirtazapine (Remeron®/Remeron RD®). Mirtazapine is an antidepressant medication used in the treatment of depression, anxiety disorders and sleep.
Use of mirtazapine in children and adolescents. A 16-year-old female presented with a resistant depression and sleep diffi- culties. She had been previously pre.
Official Title: Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders. Study Start Date: August 2010.